Release
📈 Stocks
—
📈 Bullish
Celltaxis Shares Rally as Clinical Data Validates LTA4H Inhibitor Efficacy
(just now)
Positive clinical findings published in Scientific Reports provide independent validation for Celltaxis' therapeutic approach, driving short-term investor optimism regarding its LTA4H inhibitor…